Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-masked, Placebo-controlled Study Assessing the Efficacy and Safety of Privosegtor (OCS-05) in Patients With Optic Neuritis (ON)

NCT07623668 is registered in ClinicalTrials.gov with Oculis as lead sponsor.

NCT NCT07623668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07623668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-masked, Placebo-controlled Study Assessing the Efficacy and Safety of Privosegtor (OCS-05) in Patients With Optic Neuritis (ON)
Lead sponsor
Oculis
Phase
Phase 3
Overall status
Recruiting
Start date
May 28, 2026
Completion date
December 31, 2028
Enrollment
210 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

optic neuritis